Abbott i-STAT CG4+ Cartridge Recall: 9,067,050 Units Across U.S. With 510(k) Clearance Issue (2025)
Abbott Point Of Care recalled 9,067,050 i-STAT CG4+ cartridges sold nationwide in the United States. The recall cites a lack of 510(k) premarket clearance to reflect updated sample type for lactate and measurement ranges for pH and PO2. Patients and healthcare providers should stop using the device immediately and follow manufacturer instructions.
Quick Facts at a Glance
Recall Date
August 21, 2025
Hazard Level
HIGH
Brand
Abbott Point Of Care
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS
Hazard Information
Lack of a 510(k) premarket clearance for the i-STAT CG4+ cartridge to reflect updated sample type for lactate and measurement ranges for pH and PO2.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Abbott Point Of Care Inc. or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
The i-STAT CG4+ cartridge is used with blood gas and lactate testing within point-of-care systems, enabling rapid clinical results.
Why This Is Dangerous
The lack of 510(k) clearance for updated sample type and measurement ranges could lead to misinterpretation of test results.
Industry Context
This recall is not described as part of a broader industry pattern in the provided data.
Real-World Impact
Immediate stop-use is required to prevent potential misinterpretation of critical test results in point-of-care settings.
Practical Guidance
How to identify if yours is affected
Locate List Number 03P85-25 on packaging or documentation
Verify lot numbers for affected units (all lots)
Cross-check with internal inventory records
Where to find product info
Refer to FDA recall Z-2582-2025 page and Abbott communications; contact manufacturer for confirmation
What timeline to expect
Remedy timelines are determined by Abbott and disclosed in recall communications; expect updates
If the manufacturer is unresponsive
Document all outreach attempts to Abbott
Contact the FDA or local health authority if manufacturer unresponsive
Consider legal counsel for breach of medical device clearance if applicable
How to prevent similar issues
Verify 510(k) clearance and updated parameters before accepting new lots
Keep abreast of FDA recall notices for medical devices
Train staff to quarantine recalled lots upon receipt
Maintain robust lot-tracking and supplier communications
Documentation advice
Retain recall notifications, packaging, receipts, and correspondence for records
Product Details
Model numbers: List Number 03P85-25. All lot numbers. Distribution: US nationwide. Quantity: 9,067,050 units. Remedy: Stop use and follow recall instructions. Manufacturer contact: Abbott Point Of Care Inc.
Reported Incidents
No incidents or injuries are reported in the provided data.
Key Facts
9,067,050 units recalled
List Number 03P85-25
Lack of 510(k) clearance for updated lactate sample type and pH/PO2 ranges
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW recalls 2025-2026 X1 and X2 models plus MINI Cooper and Countryman variants for front seat belt retractors with damaged torsion bars. The defect may fail to restrain occupants in a crash. Dealers will replace both front retractors at no cost. Owner letters begin November 7, 2025. VIN lookup will be available on NHTSA.gov the same day.